Health Care: Drugs

Merck & Co Inc (MRK: NYSE)

$59.52 n/a | n/a%
09/15/14 - 04:01 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 44.03B 47.27B 48.05B 45.99B
Cost of Sales 9.97B 9.47B 9.44B 11.02B
Gross Operating Profit 34.07B 37.80B 38.60B 34.97B
Selling, General, and Administrative Expenses 11.91B 12.78B 13.73B 13.24B
Research & Development 7.50B 8.17B 8.47B 10.99B
Operating Income before D & A (EBITDA) 14.65B 16.86B 16.40B 10.74B
Depreciation & Amortization 6.99B 6.98B 7.43B 7.38B
Interest Income 264.00M 232.00M 199.00M 83.00M
Other Income - Net 126.00M -634.00M -396.00M -672.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 6.35B 9.45B 8.08B 2.37B
Interest Expense 801.00M 714.00M 749.00M 715.00M
Pre-Tax Income 5.54B 8.74B 7.33B 1.65B
Income Taxes 1.03B 2.44B 942.00M 671.00M
Minority Interest 113.00M 131.00M 120.00M 121.00M
Net Income From Continuing Operations 4.52B 6.30B 6.39B 982.00M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.52B 6.30B 6.39B 982.00M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.40B 6.17B 6.27B 861.00M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.23B 6.96B 7.70B 1.97B
Preferred Dividends
Net Income Available To Common 4.52B 6.30B 6.38B 980.00M
Basic EPS from Continuing Ops. 1.49 2.03 2.04 0.28
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.49 2.03 2.04 0.28
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.49 2.03 2.04 0.28
Basic Normalized Net Income/Share 2.05 2.24 2.45 0.56
EPS fr Continuing Ops. 1.47 2.01 2.02 0.28
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.47 2.01 2.02 0.28
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 0.00 0.00
EPS, Total 1.47 2.00 2.02 0.28
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.03 2.22 2.44 0.55
Dividends Paid per Share 1.73 1.69 1.56 1.52

Portfolios with MRK

Latest MRK Headlines from TheStreet

More Financial News for MRK

Press Releases for MRK

See All Press Releases

Partner Headlines for MRK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter